Methotrexate toxicity during treatment of chronic plaque psoriasis: a case report and review of the literature. - Wikidata - wikimedia - TriplyDB

Methotrexate toxicity during treatment of chronic plaque psoriasis: a case report and review of the literature.

Methotrexate toxicity during treatment of chronic plaque psoriasis: a case report and review of the literature.

http://www.wikidata.org/entity/Q34642567

about

Methotrexate in a Real-World Psoriasis Treatment: Is It Really a Dangerous Medication for All?Low-dose methotrexate-induced ulcerated psoriatic plaques: A rare case.Effect of Nigella sativa (black seeds) against methotrexate-induced nephrotoxicity in mice.Bioadhesive Surfactant Systems for Methotrexate Skin Delivery.Methotrexate-induced nonhealing cutaneous ulcers in a nonpsoriatic patient without pancytopenia.Local reaction after subcutaneous injection of methotrexate: uncommon side effect.Methotrexate Cutaneous Toxicity following a Single Dose of 10 mg in a Case of Chronic Plaque Psoriasis: A Possible Idiosyncratic Reaction

P2860

Q33710680-7949CD36-AEDE-45D9-9151-E498B2575652 Q36733286-DB741232-FC27-4BC0-863F-4315B07DCCFD Q37621165-93D196F9-CD49-4F98-9D96-50E767A45AA1 Q38792037-0DCA1856-05B1-458F-8CB3-0ECB0FC9C197 Q41193527-AE282BBE-32BA-4872-9EC6-C7E4F6E38AB9 Q53657220-3CA02D8E-2A7D-4A57-9162-943C8D1E90CF Q58775025-4B1B13DB-38EA-49AA-8312-32563F7FD211

P2860

Methotrexate toxicity during treatment of chronic plaque psoriasis: a case report and review of the literature.

http://www.wikidata.org/entity/Q34642567

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Methotrexate toxicity during t ...... and review of the literature.

@ast

Methotrexate toxicity during t ...... and review of the literature.

@en

Methotrexate toxicity during t ...... and review of the literature.

@nl

type

label

Methotrexate toxicity during t ...... and review of the literature.

@ast

Methotrexate toxicity during t ...... and review of the literature.

@en

Methotrexate toxicity during t ...... and review of the literature.

@nl

prefLabel

Methotrexate toxicity during t ...... and review of the literature.

@ast

Methotrexate toxicity during t ...... and review of the literature.

@en

Methotrexate toxicity during t ...... and review of the literature.

@nl

P1433

Q34642567-3AEAC586-D3CC-4CD5-97D6-DAE1B090A350

P1476

Q34642567-F0FFA6E0-D9A9-4B80-875A-FD90C6C46A46

P2093

Q34642567-0D8B95AD-3252-4467-8E00-497A8B61ACFB

Q34642567-13461227-7180-4202-A341-D80F044E7195

Q34642567-46533D0E-AFE2-4E11-97A3-488A791CA322

P2860

Q34642567-0A59A66E-2278-42B8-93A4-5200100A5DE0

Q34642567-0B7C9EC1-B8D0-48BE-B947-794EA33E7D76

Q34642567-0C9A81E3-E6E9-4282-B08F-0FD4BCC753E3

Q34642567-18C9A93D-A3D5-4110-A282-462106C17896

Q34642567-1ED5A34D-1CA0-4700-9B1F-CA16996C2654

Q34642567-1FB3EB97-1AAC-4E5B-9D66-8245BACDC3CC

Q34642567-24CE6864-0FD6-42BD-9EBA-763DFC9620A5

Q34642567-2783D748-51DE-407B-89CB-B4F362DC3A99

Q34642567-2B9614C8-197F-4806-A744-A882C3A5AE67

Q34642567-34530758-B8D8-40BF-81F4-5B239E634013

P2888

Q34642567-BE6AB456-9524-486A-973D-01BF9C582BF5

P304

Q34642567-BB348179-0C78-4F1A-AA7A-41F10968713C

P31

Q34642567-1C64B93E-9F6C-4510-B5AC-315200AC9000

P356

Q34642567-586A3A86-4412-4C4B-BEED-1C71E28CE245

P433

Q34642567-EF8D6F09-A460-4537-A155-8A1210C0231F

P478

Q34642567-1868B801-A269-4921-ABB5-1893B35D1977

P50

Q34642567-5D372646-088F-462F-9067-E1DC29FAED6F

P577

Q34642567-4648E669-1393-430C-AD12-D946F5C4F79A

P5875

Q34642567-1D2F9E18-797E-4711-95DA-62D82B7737C2

P6179

Q34642567-BE87A016-87DE-4389-BE01-AB7CB1A28B46

P698

Q34642567-CA7D208C-56BF-48C1-A6AD-556BD57C823F

P932

Q34642567-9CAFEB23-31A7-4C5C-8456-1B7E36AAAEDB

P356

S13555-014-0056-Z

P1433

Dermatology and therapy

P1476

Methotrexate toxicity during t ...... and review of the literature.

@en

P2093

Amy C Foulkes

http://www.w3.org/2001/XMLSchema#string

Anja Weidmann

http://www.w3.org/2001/XMLSchema#string

N Kirkham

http://www.w3.org/2001/XMLSchema#string

P2860

Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis

Glucarpidase to combat toxic levels of methotrexate in patients

Erosion of psoriatic plaques: an early sign of methotrexate toxicity.

Methotrexate for psoriasis in weekly oral doses.

Molecular and cellular effects of methotrexate.

Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity.

Mechanisms of action of methotrexate.

Methotrexate and the photodermatitis reactivation reaction: a case report and review of the literature.

Methotrexate induced skin necrosis: a drug interaction with amiodarone?

Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study.

P2888

s13555-014-0056-z

P304

145-156

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13555-014-0056-Z

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Nick J Reynolds

P577

2014-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263293183

http://www.w3.org/2001/XMLSchema#string

P6179

1053472361

http://www.w3.org/2001/XMLSchema#string

P698

24942326

http://www.w3.org/2001/XMLSchema#string

P932

4257944

http://www.w3.org/2001/XMLSchema#string